Damora Therapeutics (DMRA) Operating Leases (2019 - 2025)
Damora Therapeutics' (DMRA) quarterly Operating Leases came in at $53000.0 in Q4 2025, down 13.11% YoY from $61000.0 in Q4 2024, and down 7.02% on a QoQ basis from $57000.0 in Q3 2025.
Damora Therapeutics (DMRA) Operating Leases (2019 - 2025) Analysis & Trends
Damora Therapeutics (DMRA) has 7 years of Operating Leases data on file, last reported at $53000.0 in Q4 2025.
- Quarterly Operating Leases fell 13.11% year-over-year to $53000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $53000.0 (down 13.11% YoY) and the FY2025 annual result came in at $53000.0, down 13.11% from the prior year.
- Operating Leases retreated to $53000.0 in Q4 2025, from $57000.0 in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $635000.0 in Q2 2021 to a low of $53000.0 in Q4 2025.
- A 5-year average of $266000.0 and a median of $234000.0 in 2023 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2023 — Operating Leases sank 79.88% — and 2024, when it dropped 7.58%.
- Tracing DMRA's Operating Leases over 5 years: stood at $448000.0 in 2021, then declined by 26.79% to $328000.0 in 2022, then slumped by 79.88% to $66000.0 in 2023, then dropped by 7.58% to $61000.0 in 2024, then retreated by 13.11% to $53000.0 in 2025.
- The last three Operating Leases figures came in at $53000.0 (Q4 2025), $57000.0 (Q3 2025), and $60000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Damora Therapeutics | 1.92 Bn | 1.38 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 53,000.00 |
| Sep 30, 2025 | 57,000.00 |
| Jun 30, 2025 | 60,000.00 |
| Mar 31, 2025 | 60,000.00 |
| Dec 31, 2024 | 61,000.00 |
| Dec 31, 2023 | 66,000.00 |
| Sep 30, 2023 | 112,000.00 |
| Jun 30, 2023 | 206,000.00 |
| Mar 31, 2023 | 234,000.00 |
| Dec 31, 2022 | 328,000.00 |
| Sep 30, 2022 | 440,000.00 |
| Jun 30, 2022 | 305,000.00 |
| Mar 31, 2022 | 402,000.00 |
| Dec 31, 2021 | 448,000.00 |
| Sep 30, 2021 | 511,000.00 |
| Jun 30, 2021 | 635,000.00 |
| Mar 31, 2021 | 544,000.00 |
| Dec 31, 2020 | 541,000.00 |
| Sep 30, 2020 | 589,000.00 |
| Dec 31, 2019 | 211,000.00 |